Skip to main content

Table 7 Proteinuria during DSG treatment: proteinuria (g/day) in the study population (n = patient number)

From: Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

  Patient
number (n)
Proteinuria (study population) P-value compared to entry
Entry 20 5.124 +/- 4,379  
cycle 4 20 2.604 +/- 2,580 0.0045
cycle 6 14 2.603 +/- 2,521 0.0392
cycle 9 12 3.374 +/- 4,787 0.028
  1. DSG, deoxyspergualin